个股档案 |
|
|
财务比率->(000416)健特生物
|
|
|
|
|
财务指标 |
健特生物 |
同行业平均(105) |
市场平均(1448) |
财务结构 |
资产负债率 |
32.53% |
29.85% |
42.24% |
资本化比率 |
0% |
2.13% |
10.39% |
固定资产净值率 |
116.41% |
91.96% |
90.05% |
资本固定化比率 |
124.17% |
77.61% |
115.45% |
偿还能力 |
流动比率 |
1.35% |
1.85% |
1.91% |
速动比率 |
1.19% |
1.43% |
1.5% |
现金比率 |
0.89% |
0.9% |
0.86% |
资本周转比率 |
- |
7.04% |
100.44% |
清算价值比率 |
302.63% |
365.06% |
301.05% |
利息支付能力(倍) |
20.62 |
27.59 |
40.22 |
经营能力 |
销售收入增长率 |
50.12% |
29.93% |
419.37% |
应收帐款周转率(次) |
21.57 |
14.46 |
30.55 |
存货周转率(次) |
16.78 |
4.27 |
34.25 |
流动资产周转率 |
1.66% |
1.7% |
1.17% |
总资产周转率 |
0.57% |
0.81% |
0.58% |
净资产增长率 |
-0.72% |
71.75% |
149.4% |
获利能力 |
毛利率 |
47.72% |
33.58% |
28.22% |
营业利润率 |
33.48% |
11.08% |
9.09% |
利润率 |
14.49% |
10.23% |
10.23% |
净利润增长率 |
-249.77% |
-4.29% |
762.71% |
净资产收益率 |
16.08% |
8.57% |
7.48% |
总资产收益率 |
8.19% |
6.27% |
4.18% |
|
|
|